---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-013248"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2021-10-18T23:59:59+00:00"
generated_at: "2026-06-28T20:16:05.257773+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Director Rajeev Shah resigns; C. Daniel Myers appointed to board

## Summary
- Rajeev Shah resigned effective Oct 15, 2021; no disagreement with company on operations.
- C. Daniel Myers appointed as Class III director, term expiring at 2023 annual meeting.
- Myers is CEO of MediPrint Ophthalmics, former CEO and co-founder of Alimera Sciences.
- Myers received option to purchase 42,000 shares at $2.21, vesting over three years.
- Myers also appointed to Compensation Committee and Nominating and Corporate Governance Committee.

## SEC filing metadata
- accession: 0001558370-21-013248
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2021-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837021013248/0001558370-21-013248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837021013248/kala-20211014x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-013248
- JSON: https://secwatch.observer/filing/0001558370-21-013248.json
- Plain text: https://secwatch.observer/filing/0001558370-21-013248.txt

## Key facts
- Executive change
  Rajeev Shah resigned as member of the Board of Directors at KALA BIO, Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On October 14, 2021, Rajeev Shah notified Kala Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), which resignation was effective on October 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837021013248/0001558370-21-013248-index.htm
- Executive change
  C. Daniel Myers was appointed as member of the Board of Directors at KALA BIO, Inc..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: On October 15, 2021, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed C. Daniel Myers as a member of the Board, effective immediately, to fill the vacancy created by the resignation of Mr. Shah.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837021013248/0001558370-21-013248-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.